However, neither IVIG nor albumin can prevent the viral spread; thus, non‐SARS‐CoV‐2‐targeting product therapies only have therapeutic effects and should only be considered as supplements to control the COVID‐19 pandemic. The gene discussed is ALB; the disease is COVID-19.